Thomas Goodin

487 total citations
28 papers, 382 citations indexed

About

Thomas Goodin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Thomas Goodin has authored 28 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 16 papers in Physiology and 3 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Thomas Goodin's work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (13 papers) and Respiratory Support and Mechanisms (9 papers). Thomas Goodin is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (13 papers) and Respiratory Support and Mechanisms (9 papers). Thomas Goodin collaborates with scholars based in United States, United Kingdom and India. Thomas Goodin's co-authors include Gary T. Ferguson, Edward Kerwin, Alistair Wheeler, Robert Tosiello, Shahin Sanjar, James F. Donohue, Fredric J. Pashkow, Fadlo R. Khuri, Margaret S. Dordal and George R. Blumenschein and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and Critical Care Medicine.

In The Last Decade

Thomas Goodin

27 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Goodin United States 10 168 128 72 42 38 28 382
Francesco Mazza Italy 12 108 0.6× 78 0.6× 137 1.9× 23 0.5× 70 1.8× 19 349
J.A. Oliver United States 6 73 0.4× 42 0.3× 79 1.1× 32 0.8× 12 0.3× 11 673
Megan T. Quintana United States 11 40 0.2× 54 0.4× 206 2.9× 19 0.5× 26 0.7× 25 376
Fotini Sampalis Canada 10 81 0.5× 75 0.6× 85 1.2× 10 0.2× 143 3.8× 14 507
Chris Wambi United States 12 186 1.1× 102 0.8× 123 1.7× 13 0.3× 39 1.0× 19 472
Mai Nguyen United States 7 81 0.5× 89 0.7× 89 1.2× 11 0.3× 9 0.2× 15 329
Takehiko Hanaki Japan 15 204 1.2× 101 0.8× 126 1.8× 41 1.0× 274 7.2× 80 675
C Howe Australia 7 42 0.3× 88 0.7× 79 1.1× 38 0.9× 22 0.6× 7 601
Cristóbal Zaragozá Spain 7 39 0.2× 79 0.6× 81 1.1× 24 0.6× 32 0.8× 18 358
María Marta Rivas Argentina 8 42 0.3× 69 0.5× 98 1.4× 63 1.5× 188 4.9× 21 498

Countries citing papers authored by Thomas Goodin

Since Specialization
Citations

This map shows the geographic impact of Thomas Goodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Goodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Goodin more than expected).

Fields of papers citing papers by Thomas Goodin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Goodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Goodin. The network helps show where Thomas Goodin may publish in the future.

Co-authorship network of co-authors of Thomas Goodin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Goodin. A scholar is included among the top collaborators of Thomas Goodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Goodin. Thomas Goodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanania, Nicola A., Abebaw Mengistu Yohannes, Ayca Ozol-Godfrey, et al.. (2021). Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies. International Journal of COPD. Volume 16. 865–875. 4 indexed citations
2.
Donohue, James F., Ayca Ozol-Godfrey, Thomas Goodin, & Shahin Sanjar. (2020). <p>The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies</p>. International Journal of COPD. Volume 15. 745–754.
3.
Ohar, Jill, Ayca Ozol-Godfrey, Thomas Goodin, & Shahin Sanjar. (2020). <p>Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate</p>. International Journal of COPD. Volume 15. 995–1004. 4 indexed citations
4.
Carlin, Brian, Gary T. Ferguson, Ayca Ozol-Godfrey, Thomas Goodin, & Shahin Sanjar. (2020). The Effect of Metabolic Syndrome Status on Lung Function and Patient-reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 7(4). 315–326. 1 indexed citations
5.
Ohar, Jill, et al.. (2019). <p>Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of the GEM1 and GEM2 12-week studies</p>. International Journal of COPD. Volume 14. 461–470. 2 indexed citations
6.
7.
Leaker, Brian, Dave Singh, Grant C. Nicholson, et al.. (2019). Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease. Respiratory Research. 20(1). 132–132. 4 indexed citations
8.
Ohar, Jill, Robert Tosiello, Thomas Goodin, & Shahin Sanjar. (2018). Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4. International Journal of COPD. Volume 14. 27–37. 2 indexed citations
9.
10.
Ferguson, Gary T., Robert Tosiello, Shahin Sanjar, & Thomas Goodin. (2018). Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 6(1). 86–99. 3 indexed citations
11.
Ferguson, Gary T., et al.. (2017). In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(3). 162–169. 24 indexed citations
12.
13.
Donohue, James F., Thomas Goodin, Robert Tosiello, & Alistair Wheeler. (2017). Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies. Respiratory Research. 18(1). 202–202. 6 indexed citations
14.
Ferguson, Gary T., Thomas Goodin, Robert Tosiello, Alistair Wheeler, & Edward Kerwin. (2017). Long-term safety of glycopyrrolate/eFlow® CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study. Respiratory Medicine. 132. 251–260. 19 indexed citations
15.
Khan, Sanjoy K., Tadeusz Maliñski, Ronald P. Mason, et al.. (2010). Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model. Thrombosis Research. 126(4). 299–305. 40 indexed citations
16.
Serebruany, Victor L., Alex I. Malinin, Thomas Goodin, & Fredric J. Pashkow. (2010). The In Vitro Effects of Xancor, a Synthetic Astaxanthine Derivative, on Hemostatic Biomarkers in Aspirin-Naïve and Aspirin-Treated Subjects With Multiple Risk Factors for Vascular Disease. American Journal of Therapeutics. 17(2). 125–132. 13 indexed citations
17.
Goodin, Thomas, et al.. (1994). A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock. Critical Care Medicine. 22(4). 680–689. 23 indexed citations
18.
Geyer, Robert P., et al.. (1987). Near Total Blood Exchange with Perfluorochemical Preparations. MRS Proceedings. 110. 1 indexed citations
19.
Goodin, Thomas, et al.. (1983). A method for evaluation of blood substitutes in the conscious animal. American Journal of Physiology-Heart and Circulatory Physiology. 245(3). H519–H523. 7 indexed citations
20.
Monforte, Joseph R., Robert H. Gault, John E. Smialek, & Thomas Goodin. (1983). Toxicological and Pathological Findings in Fatalities Involving Pentazocine and Tripelennamine. Journal of Forensic Sciences. 28(1). 90–101. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Mazza Breakdown of academic impact, for papers by J.A. Oliver Breakdown of academic impact, for papers by Megan T. Quintana Breakdown of academic impact, for papers by Fotini Sampalis Breakdown of academic impact, for papers by Chris Wambi Breakdown of academic impact, for papers by Mai Nguyen Breakdown of academic impact, for papers by Takehiko Hanaki Breakdown of academic impact, for papers by C Howe Breakdown of academic impact, for papers by Cristóbal Zaragozá Breakdown of academic impact, for papers by María Marta Rivas
Rankless by CCL
2026